|
TXNDC9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.032200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.995000E-01 |
| Normal-vs-Stage2 |
9.100400E-01 |
| Normal-vs-Stage3 |
4.998200E-01 |
| Normal-vs-Stage4 |
1.970040E-01 |
| Stage1-vs-Stage2 |
5.484000E-01 |
| Stage1-vs-Stage3 |
8.390800E-01 |
| Stage1-vs-Stage4 |
3.253900E-02 |
| Stage2-vs-Stage3 |
7.004800E-01 |
| Stage2-vs-Stage4 |
2.810200E-01 |
| Stage3-vs-Stage4 |
8.171800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.886600E-01 |
| Normal-vs-AfricanAmerican |
9.597000E-01 |
| Normal-vs-Asian |
6.862400E-01 |
| Caucasian-vs-AfricanAmerican |
6.668600E-01 |
| Caucasian-vs-Asian |
8.532800E-01 |
| AfricanAmerican-vs-Asian |
7.896600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.653000E-01 |
| Normal-vs-Female |
3.639400E-01 |
| Male-vs-Female |
3.191400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.518150E-01 |
| Normal-vs-Age(41-60Yrs) |
8.783600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.865400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.107800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.040400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.387600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.245800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.625600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.167200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.188600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.281800E-01 |
| Classical-VS-Follicular |
1.310390E-02 |
| Classical-VS-Other |
7.556100E-02 |
| Classical-VS-Normal |
1.470190E-01 |
| Tall-VS-Follicular |
2.177800E-02 |
| Tall-VS-Other |
4.775700E-02 |
| Tall-VS-Normal |
7.294000E-02 |
| Follicular-VS-Other |
5.774600E-01 |
| Follicular-VS-Normal |
2.532000E-01 |
| Other-VS-Normal |
1.299450E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.206400E-01 |
| Normal-vs-N1 |
1.766960E-01 |
| N0-vs-N1 |
1.433410E-01 |
|
|
